Schering-Plough Announces FDA Approval Of PEGINTRON(TM) And REBETOL(R) Combination Therapy For Treating Pediatric Hepatitis C First and only approved peginterferon in combination with ribavirin for previously untreated children with chronic hepatitis C addresses unmet medical need Schering-Plough Corporation (NYSE: SGP) today announced that the U.S.
Source: www.medicalnewstoday.comNew Website For People With Multiple Sclerosis MS Invigor8, a website developed by researchers at the University of Southampton, to treat fatigue in people with Multiple Sclerosis (MS) using Cognitive Behaviour Therapy (CBT) will be completed on Friday (12 December) and is ready to be trialled.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
